Treeline: Making medicines at the highest level
Treeline is a clinical-stage biopharma company with $1.1 billion in funding and three Phase 1 trials in cancer.
Nabla Bio: Designing antibodies with atomic precision
Nabla Bio is an AI antibody drug design company with collaborations with AstraZeneca, Bristol Myers Squibb and Takeda.